-
Recent Job Cuts in FDA and other pharmaceutical companies, and the impact on the industry
Muhammad Asim Niazi
May 15, 2025
The pharma industry faces downsizing in various areas, where a number of employees are fired or relieved of their duties.In addition to the manufacturing industry, the FDA also faces job and funding cuts.
-
Sanofi aims to save €2B through job cuts, smarter buying
fiercepharma
December 12, 2019
Like many a corporate rejuvenation plan, CEO Paul Hudson's blueprint for Sanofi includes some hefty cost cutting.
-
Job cuts limit cardiovascular and diabetes research and development
europeanpharmaceuticalreview
June 26, 2019
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
-
Eli Lilly plots 250 job cuts in €100M revamp of French plant
fiercepharma
January 13, 2019
Boehringer Ingelheim and Sanofi aren't the only pharma companies chopping jobs in France. Now, Eli Lilly says?it's cutting 250 positions as part of a "modernization" effort at a plant in Fegersheim.
-
With Advair generics looming, GSK sharpens ax for 650 job cuts
fiercepharma
December 12, 2018
After a business review unveiled in July—and ahead of new challenges—GlaxoSmithKline is sharpening its jobs ax to cut 650 across its U.S. business.
-
Boehringer follows Sanofi with job cuts in France
pharmaphorum
December 12, 2018
Boehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more than 300 jobs, adding to several hundred losses at Sanofi last week.
-
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threat
fiercepharma
November 02, 2018
Diabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have cut about 1,300 employees by the end of 2018.
-
Working through CEO swap, Pfizer plots job cuts in drive for 'simpler' structure
fiercepharma
October 19, 2018
A week after Pfizer unveiled a reshuffled executive team that'll report to incoming CEO Albert Bourla, the company said it's restructuring to simplify management and boost efficiency. And this latest move means job ...
-
GlaxoSmithKline sharpens ax for 650 job cuts—450 in sales—to channel money toward new launches, R&D
fiercepharma
September 28, 2018
After a business review unveiled in July—and ahead of new challenges—GlaxoSmithKline is sharpening its jobs ax to cut 650 across its U.S. business. On the block are 450 field sales positions, plus another 100 each at its ...
-
With drugs pipeline in focus, Bayer considers job cuts
financialexpress
September 05, 2018
The savings that Bayer – the inventor of aspirin and maker of Yasmin birth control pills – could make as part of the overhaul would give it financial wiggle room as it competes with larger rivals to buy the right to promising treatments from biotech firms